AbbVie beats forecast as Humira sales surge

(Reuters) - AbbVie Inc on Friday reported stronger-than-expected results for the third quarter, when booming sales of its Humira arthritis treatment and Synthroid thyroid replacement drug more than offset lower demand for other medicines.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news